Home » Newsletters » BioWorld

BioWorld

Aug. 28, 1992

View Archived Issues

APPOINTMENTS AND ADVANCEMENTS

DEPRENYL DIALS DAMAGE CONTROL

ENZON, SCHERING START INTRON A TRIALS

NIH CONDITIONS FOR NOT PATENTING GENES

MYCOGEN COMPLETES $135 MILLION DEAL

CAMBRIDGE NEURO BEGINS TRIALS

CEPHALON BEGINS ALS TRIALS IN U.S.

CAMBRIDGE BIO COMPLETES ACQUISITION